Evidence map›Paper›PMID 32064372›Full record

ArticleACS omega2020

Computational Analysis of Crystallization Additives for the Identification of New Allosteric Sites.

Jade Fogha, Julien Diharce, Alan Obled, Samia Aci-Sèche, Pascal Bonnet

Abstract read
In one paragraph

Article in ACS omega, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Machine learning and protein allostery.Trends in biochemical sciences · 2023
    Review
  5. Estimating the Similarity between Protein Pockets.International journal of molecular sciences · 2022
    Review
  6. Article
  7. Article
  8. Engineering an Allosteric Control of Protein Function.The journal of physical chemistry. B · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jade FoghaInstitut de Chimie Organique et Analytique, Université d'Orléans, UMR CNRS 7311, BP6759, 45067 Orléans Cedex 2, France.
Julien DiharceInstitut de Chimie Organique et Analytique, Université d'Orléans, UMR CNRS 7311, BP6759, 45067 Orléans Cedex 2, France.
Alan ObledInstitut de Chimie Organique et Analytique, Université d'Orléans, UMR CNRS 7311, BP6759, 45067 Orléans Cedex 2, France.
Samia Aci-SècheInstitut de Chimie Organique et Analytique, Université d'Orléans, UMR CNRS 7311, BP6759, 45067 Orléans Cedex 2, France.
Pascal BonnetInstitut de Chimie Organique et Analytique, Université d'Orléans, UMR CNRS 7311, BP6759, 45067 Orléans Cedex 2, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Allosteric effect can modulate the biological activity of a protein. Thus, the discovery of new allosteric sites is very attractive for designing new modulators or inhibitors. Here, we propose an innovative way to identify allosteric sites, based on crystallization additives (CA), used to stabilize proteins during the crystallization process. Density and clustering analyses of CA, applied on protein kinase and nuclear receptor families, revealed that CA are not randomly distributed around protein structures, but they tend to aggregate near common sites. All orthosteric and allosteric cavities described in the literature are retrieved from the analysis of CA distribution. In addition, new sites were identified, which could be associated to putative allosteric sites. We proposed an efficient and easy way to use the structural information of CA to identify allosteric sites. This method could assist medicinal chemists for the design of new allosteric compounds targeting cavities of new drug targets.

Identifiers

PMID32064372
PMCPMC7016913

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.